• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A role of antifibrotics in the treatment of Scleroderma-ILD?

作者信息

Antoniou Katerina M, Trachalaki Athina, Tzouvelekis Argyris, Poletti Venerino, Vasarmidi Eirini, Sfikakis Petros, Bouros Demosthenes

机构信息

Department of Respiratory Medicine, Medical School, University of Crete, Heraklion, Greece.

Department of Respiratory Medicine, Medical School, University of Crete, Heraklion, Greece.

出版信息

Pulmonology. 2020 Jan-Feb;26(1):1-2. doi: 10.1016/j.pulmoe.2019.08.004. Epub 2019 Oct 23.

DOI:10.1016/j.pulmoe.2019.08.004
PMID:31653592
Abstract
摘要

相似文献

1
A role of antifibrotics in the treatment of Scleroderma-ILD?抗纤维化药物在系统性硬化症相关间质性肺疾病治疗中的作用？
Pulmonology. 2020 Jan-Feb;26(1):1-2. doi: 10.1016/j.pulmoe.2019.08.004. Epub 2019 Oct 23.
2
Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.硬皮病相关间质性肺病患者咳嗽及咳嗽特异性生活质量改善：硬皮病肺部研究II的结果
Chest. 2017 Apr;151(4):813-820. doi: 10.1016/j.chest.2016.11.052. Epub 2016 Dec 22.
3
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.环磷酰胺与霉酚酸酯用于硬皮病间质性肺病（SSc-ILD）诱导治疗的单中心回顾性分析
Arthritis Res Ther. 2016 Jun 2;18(1):123. doi: 10.1186/s13075-016-1015-0.
4
Management of systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关间质性肺疾病的管理。
Curr Opin Rheumatol. 2019 May;31(3):241-249. doi: 10.1097/BOR.0000000000000592.
5
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.系统性硬皮病肺研究 II 中免疫抑制后 CT 定量间质性肺病的纵向变化。
Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC.
6
David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?以弱胜强：我们能否攻克并战胜系统性硬化症中的间质性肺病？
Clin Exp Rheumatol. 2007 Mar-Apr;25(2):169-71.
7
Scleroderma-related interstitial lung disease: principles of management.硬皮病相关间质性肺病：管理原则。
Expert Rev Respir Med. 2019 Apr;13(4):357-367. doi: 10.1080/17476348.2019.1575732. Epub 2019 Feb 11.
8
A new therapy for systemic sclerosis-associated interstitial lung disease.一种治疗系统性硬化症相关间质性肺病的新疗法。
Respir Investig. 2020 Jul;58(4):227-229. doi: 10.1016/j.resinv.2020.03.005. Epub 2020 May 22.
9
Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.使用霉酚酸酯治疗硬皮病相关间质性肺疾病。
Respir Med. 2008 Jan;102(1):150-5. doi: 10.1016/j.rmed.2007.07.021. Epub 2007 Sep 5.
10
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.系统性硬皮病相关间质性肺病 - 个体化免疫抑制治疗和肺功能病程：EUSTAR 组的结果。
Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z.

引用本文的文献

1
Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience.尼达尼布治疗结缔组织病相关间质性肺病（CTD-ILD）患者的疗效和安全性：一项单中心真实世界研究经验
Diagnostics (Basel). 2023 Mar 23;13(7):1221. doi: 10.3390/diagnostics13071221.
2
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients.高分辨率计算机断层扫描：改善系统性硬化症相关间质性肺病患者护理中的利弊
Diagnostics (Basel). 2021 Oct 22;11(11):1960. doi: 10.3390/diagnostics11111960.
3
Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey.
进行性纤维化间质性肺疾病的内型分类：重要的是最终目的地而非旅程。
EBioMedicine. 2020 Jan;51:102591. doi: 10.1016/j.ebiom.2019.11.052. Epub 2020 Jan 2.